o utcomes r esearch providing the evidence for evidence-based medicine ©
Post on 19-Dec-2015
215 views
TRANSCRIPT
![Page 1: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/1.jpg)
OUTCOMES RESEARCH
Providing the evidence for evidence-based medicine©
![Page 2: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/2.jpg)
Thermoregulation & Heat Balance
Thermoregulation During General Anesthesia
Temperature Monitoring
Consequences of Hypothermia
Maintaining Normothermia
www.or.org
![Page 3: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/3.jpg)
Normal Thermoregulation
37
36
Sweating
Active vasodilation
Vasoconstriction
Shivering
![Page 4: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/4.jpg)
Anesthesia Impairs Regulation
0.0 2.0 4.0 6.0 8.0
[P ro p o f o l] (µ g/m l )
0.0 0.1 0.2 0.3
[A l fe n tan i l ] (µ g/m l )
30
32
34
36
38
0.0 2.0 4.0 6.0
[D e s f l u ran e ] (% )
C o n s tr ic ti o n
S h i v eri n g
T h re s h o l d
(°C )
S w eati n g
32
34
38
36
30
[D e x m ed e to m i d i n e ] (n g / m l)0.3 0.6 0.9
![Page 5: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/5.jpg)
Hypothermia During Anesthesia
0 2 4 6
∆ C o r e
T e m p
( ° C )
E l a p s e d T i m e ( h )
- 1
- 3
- 2
0
![Page 6: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/6.jpg)
Redistribution Hypothermia
Core37°C
Vasoconstricted
Periphery31-35°C
Anesthesia
Periphery33-35°C
Core36°C
Vasodilated
![Page 7: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/7.jpg)
Redistribution Hypothermia
![Page 8: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/8.jpg)
Intraoperative Heat Transfer
Evaporation
Conduction
Convection
Radiation
![Page 9: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/9.jpg)
Vasoconstriction Constrains Heat
![Page 10: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/10.jpg)
Summary: General Anesthesia
Central thermoregulatory inhibition•Dose-dependent increase in interthreshold range•More impairment of cold than warm responses
Intraoperative hypothermia•Redistribution of heat (initial decrease)•loss exceeding heat production (slow linear decrease)
Core Temperature Plateau•Decreased cutaneous heat loss; thermal steady-state•Separation of core and peripheral compartments
![Page 11: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/11.jpg)
Temperature MonitoringCore Sites
•Pulmonary artery•Distal esophagus•Nasopharynx•Tympanic membrane thermocouple
Other generally-reliable sites•Mouth•Axilla•Bladder•Forehead skin with 2°C compensation
Sub-optimal•Infrared “tympanic”•Rectal
![Page 12: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/12.jpg)
Benefits of Mild HypothermiaCerebral ischemia and hypoxemia
•1-3°C provides marked protection in animals
No benefit in major human trials•Brain trauma: Clifton, et al.•Anurysm surgery: Todd, et al.•Acute myocardial infarction: Dixon, et al.
Improves neurologic outcome after cardiac arrest•Bernard, et al.•Hypothermia after cardiac arrest study group
Improves neurologic outcome in asphyxiated neonates•Shankaren, et al.
Malignant hyperthermia•2-3°C delays or prevents triggering and decreases severity
![Page 13: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/13.jpg)
Myocardial Outcomes: Frank, et al.
0Hypothermic
35.3 ± 0.1
P = 0.04
Normothermic36.7 ± 0.1
2
4
6
8
10
Core Temperature (°C)
![Page 14: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/14.jpg)
Perioperative Blood Loss
16% less blood loss (95% CI 4-28%, P = 0.009)
![Page 15: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/15.jpg)
Wound Infections: Kurz, et al.
Normothermia is more effective than antibiotics!
0
5
10
15
20
25
0
5
10
15
20
25
Core Temperature (°C)
Hypothermic34.7 ± 0.6
Normothermic36.6 ± 0.5
Hypothermic34.7 ± 0.6
Normothermic36.6 ± 0.5
P < 0.01P = 0.001
![Page 16: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/16.jpg)
Duration of Vecuronium
6 0
2 0
4 0
8 0
D u r a t i o n
o f A c t i o n
( m i n )
H y p o t h e r m i c
( 3 4 . 6 ± 0 . 3 ° C )
N o r m o t h e r m i c
( 3 6 . 6 ± 0 . 1 ° C )
![Page 17: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/17.jpg)
Recovery Duration
0
20
40
60
80
100
40 80 120 160
T im e
(m in )
F i t F o r D i s c h a rg e
F i t F o r D i s c h a r g e
&
≥ 36 ° CT c
h y p o t h e r -
m i c
n o r m o t h e r -
m i c n o rm o t h e r -
m i c
h y p o t h e r -
m i c
D is ch arg e
F ro m P A C U
(% )
40 80 120 160
T im e
(m in )
![Page 18: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/18.jpg)
Thermal Discomfort
T h e r m a l
C o m f o r t
( m m )
0
2 0
4 0
6 0
0 1 2 3 4 5 6
T i m e ( h )
N o r m o t h e r m i c
H y p o t h e r m i c
![Page 19: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/19.jpg)
Summary: Consequences
Benefits•Protects against cerebral ischemia (cardiac arrest)•Decreases triggering and severity of MH
Major complications•Morbid myocardial outcomes•Bleeding and increased transfusion requirement•Wound infections and prolonged hospitalization
Other complications•Decreased drug metabolism•Prolonged recovery duration•Thermal discomfort
![Page 20: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/20.jpg)
Insulating Covers
P l a s t i c
P a p e r
C o t t o n
C l o t h
6 0
8 0
1 0 0
1 2 0
H e a t
L o s s
( W )
- 2 0 - 0 2 0 4 0 6 0
T i m e ( m i n )
Thermal-Drape
![Page 21: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/21.jpg)
More Layers Do Not Help Much
T i m e ( m i n )
0
2 0
4 0
6 0
8 0
1 0 0
- 2 0 0 2 0 4 0 6 0
H e a t
L o s s
( W )
1 W a r m
1 U n w a r m e d
3 W a r m
3 U n w a r m e d
![Page 22: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/22.jpg)
Active Warming
-3
-2
-1
0
0 60 120 180
Time (min)
Water Blanket
Air Warmer
Control
Humidifier
Δ T (° )C
![Page 23: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/23.jpg)
Prewarming Prevents Hypothermia
T M
( ° C )
3 4
3 5
3 6
3 7
3 8
T i m e ( m i n )
- 6 0 0 6 0
N o W a r m i n g
P r e - W a r m i n g
![Page 24: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/24.jpg)
Fluid Warming
Cooling by intravenous fluids•0.25°C per liter crystalloid at ambient temperature•0.25°C per unit of blood from refrigerator
Fluid warming does not prevent hypothermia!•Most core cooling from redistribution•90% of heat loss is from anterior skin surface
Cooling prevented by warming solutions•Type of warmer usually unimportant•Use high-flow systems for major trauma
![Page 25: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/25.jpg)
The Rule: Monitor and Warm
Monitor core temperature•General anesthesia >30 minutes•Large procedures under neuraxial anesthesia
Maintain normothermia•Core temperature ≥36°C
Forced-air heating•Best combination of efficacy, cost, and safety
![Page 26: O UTCOMES R ESEARCH Providing the evidence for evidence-based medicine ©](https://reader036.vdocuments.site/reader036/viewer/2022062515/56649d295503460f949fe1e3/html5/thumbnails/26.jpg)
OUTCOMES RESEARCH
Providing the evidence for evidence-based medicine©